Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction

American Journal of Cardiology

Volumn 86, Issue 4, 2000, Pages 379-384

  Choussat, Rémi ^a   Montalescot, Gilles ^a   Collet, Jean Philippe ^a   Jardel, Claude ^a   Ankri, Annick ^a   Fillet, Anne Marie ^a   Thomas, Danielle ^b   Raymond, Josette ^c   Bastard, Jean Philippe ^a   Drobinski, Gérard ^a   Orfila, Jeanne ^b   Agut, Henri ^a   Thomas, Daniel ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; CYTOMEGALOVIRUS ANTIBODY; FIBRINOGEN; INTERLEUKIN 6; NEOPTERIN; PROCALCITONIN; SERUM AMYLOID A;

ACUTE HEART INFARCTION; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SEROPREVALENCE; UNSTABLE ANGINA PECTORIS;

ACUTE-PHASE PROTEINS; AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEMODYNAMIC PROCESSES; HUMANS; INFECTION; INFLAMMATION; LINEAR MODELS; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0034663702     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00950-4     Document Type: Article

References (30)

1. Haverkate F., Thompson S.G., Pyke S.D.M., Gallimore J.R., Pepys M.B. Production of C-reactive protein and the risk of coronary events in stable and unstable angina. Lancet. 349:1997;462-466.
2. Anderson J., Carlquist J., Muhlestein J., Horne B., Elmer S. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infraction. J Am Coll Cardiol. 32:1998;35-41.
3. Gieseg S.P., Reibnegger G., Wachter H., Esterbauer H. 7,8-Dihydroneopterin inhibits low-density-lipoprotein oxidation in-vitro-evidence that this macrophage secreted pteridine is an antioxidant. Free Radic Res. 23:1995;123-126.
4. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 341:1993;515-518.
5. Biasucci L., Vitelli A., Liuzzo G., Altamura S., Caligiuri G., Monaco C., Rebuzzi A.G., Ciliberto G., Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 94:1996;874-877.
6. Miyao Y., Yasue H., Ogawa H., Misumi I., Masuda T., Sakamoto T. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J. 126:1993;1299-1304.
7. Neumann F.J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., Schömig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 92:1995;748-755.
8. Toss H., Lindahl B., Siegbahn A., Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation. 96:1997;4204-4210.
9. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 331:1994;417-424.
10. Becker R., Cannon C., Bovill E.G., Tracy R.P., Thompson B., Knatterud G.L., Randall A., Braunwald B. Prognosis value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB trial). Am J Cardiol. 78:1996;142-147.
11. Weiss G., Willeit J., Kiechl S., Fuchs D., Jarosch E., Oberhollenzer F., Reibnegger G., Tilz G.P., Gerstenbrand F., Wachter H. Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis. 106:1994;263-271.
12. Schumacher M., Halwachs G., Tatzber F., Fruhwald F., Zweiker R., Watzinger N., Eber B., Wilders-Truschnig M., Esterbauer H., Klein W. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol. 30:1997;703-707.
13. Patel P., Mendall M.A., Carrington D., Strachan D., Leatham E., Molineaux N., Levy J., Blakeston C., Seymour C.A., Camm A.J., Northfield T.C. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 311:1995;711-714.
14. Patel P., Carrington D., Strachan D., et Leatham E., Goggin P., Northfield T.C., Mendall M.A. Fibrinogen a link between chronic infection and coronary heart disease . Lancet. 343:1994;1634-1635.
15. McDonagh T.A., Woodward M., Morrison C.E., McMurray J.J.V., Tunstall-Pedoe H., Lowe G.D.O., McColl K.E.L., Dragie H.J. Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J. 18:1997;1257-1260.
16. Pasceri V., Cammarota G., Patti G., Cuoco L., Gasbarrini A., Grillo R.L., Fedeli G., Gasbarrini G., Maseri A. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation. 97:1998;1675-1679.
17. Folsom A.R., Nieto J., Sorlie P., Chambless L.E., Graham D.Y. Helicobacter pylori seropositivity and coronary heart disease incidence. Circulation. 98:1998;845-850.
18. Wald N.J., Law M.R., Morris J.K., Bagnall A.M. Helicobacter pylori infection and mortality from ischemic heart disease negative results from a large, prospective study . BMJ. 315:1997;1199-1201.
19. Campbell L.A., O'Brien E.R., Cappucio A.L., Kuo C., Wang S., Stewart D., Patton D.L., Cummings P.K., Grayston J.T. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 172:1995;585-588.
20. Gupta S., Leatham E.W., Carrington D., Mendall M.A., Kaski J.C., Camm A.J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in the male survivors of myocardial infarction. Circulation. 96:1997;404-407.
21. Gurfinkel E., Bozovich G., Daroca A., Beck G., Mautner B. Randomized study ROXIS pilot study, roxithromycin in non-Q-wave coronary syndromes . Lancet. 350:1997;404-407.
22. Gurfinkel E., Bozovich G., Beck E., Testa E., Livellara B., Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study. Eur Heart J. 20:1999;121-127.
23. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Makela P.H., Huttunen J.K., Valtonen V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986.
24. Davidson M., Kuo C.C., Middaugh J.P., Campbell L.A., Wang S.P., Newman W.P., Finley J.C., Grayston J.T. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 98:1998;628-633.
25. Ridker P.M., Kundsin R.B., Stampfer M.J., Poulin S., Hennekens C.H. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation. 99:1999;1161-1164.
26. Epstein S.E., Speir E., Zhou Y.F., Guetta E., Leon M., Finkel T. The role of infection in restenosis and atherosclerosis focus on cytomegalovirus . Lancet. 348:1996;S13-S17.
27. Zhou Y.F., Leon M.B., Waclawiw M.A., Popma J.J., Yu Z.X., Finkel T., Epstein S.E. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 335:1996;624-630.
28. Montalescot G., Ankri A., Vicaut E., Drobinski G., Grogogeat Y., Thomas D. Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation. 92:1995;31-38.
29. Montalescot G., Collet J.P., Choussat R., Thomas D. Fibrinogen as a risk factor for coronary heart disease. Eur Heart J. 19:1998;H11-H17.
30. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease is there a link? Lancet. 350:1997;430-436.